Table 1 Comparison of clinical and conventional imaging characteristics between benign and malignant groups
Variables | Benign (n = 41) | Malignant (n = 38) | p |
|---|---|---|---|
Age | 47.00 [38.00, 50.00] | 48.50 [42.25, 56.50] | 0.159 |
CA153 | 8.00 [5.50, 9.90] | 9.05 [5.23, 12.85] | 0.301 |
CA125 | 7.70 [5.30, 13.10] | 6.70 [5.58, 12.30] | 0.495 |
CA199 | 14.23 [8.60, 22.37] | 13.86 [8.80, 20.87] | 0.549 |
CEA | 1.00 [0.51, 1.82] | 0.85 [0.47, 1.94] | 0.768 |
Tumor longest diameter | 14.40 [10.60, 17.50] | 15.40 [13.43, 20.82] | 0.116 |
Menopause stage | 0.203 | ||
Post | 6 (14.63) | 11 (28.95) | Â |
Pre | 35 (85.37) | 27 (71.05) | Â |
internal enhancement pattern | 0.112 | ||
Homogeneous | 27 (65.85) | 23 (60.53) | Â |
Heterogeneous | 5 (12.20) | 11 (28.95) | Â |
Rim enhancement | 9 (21.95) | 4 (10.53) | Â |
TIC | 0.428 | ||
I | 13 (31.71) | 13 (34.21) | Â |
II | 15 (36.59) | 9 (23.68) | Â |
III | 13 (31.71) | 16 (42.11) | Â |
Tumor position | 0.163 | ||
Upper-inner quadrant | 9 (21.95) | 12 (31.58) | Â |
Lower-inner quadrant | 8 (19.51) | 4 (10.53) | Â |
Upper-outer quadrant | 15 (36.59) | 19 (50.00) | Â |
Lower-outer quadrant | 9 (21.95) | 3 (7.89) | Â |
Breast dense | 0.970 | ||
Fat | 1 (2.44) | 1 (2.63) | Â |
Fibro-glandular tissue | 6 (14.63) | 7 (18.42) | Â |
Heterogeneous fibro-glandular tissue | 20 (48.78) | 17 (44.74) | Â |
Extreme fibro-glandular tissue | 14 (34.15) | 13 (34.21) | Â |